Results 81 to 90 of about 13,664 (205)
Monitoring prohemostatic treatment in bleeding patients [PDF]
, 2012 Acutely bleeding patients are commonly found in the trauma and major surgery scenarios. They require prompt and effective treatment to restore an adequate hemostatic pattern, to avoid serious and sometimes life-threatening complications.Different ...
Baryshnikova, E, Colella, D, Ranucci, M
core +1 more source
Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood [PDF]
, 2007 Background During gram-negative sepsis, lipopolysaccharide (LPS) induces tissue factor expression on monocytes. The resulting disseminated intravascular coagulation leads to tissue ischemia and worsens the prognosis of septic patients.
Christoph Sucker +3 more
core +2 more sources
PlateletsMutations in the ITGA2B or ITGB3 gene that encodes for the αIIbβ3 platelet integrin usually cause Glanzmann thrombasthenia (GT). This study aims to investigate the clinical characteristics of a pedigree exhibiting an inherited hemorrhagic disorder ...
Xiangcheng Liao +7 more
doaj +1 more source
Factor VII deficiency and pregnancy: a case report and review of literature [PDF]
, 2010 Factor VII deficiency is one of the \u27rare inherited disorders of coagulation.\u27 Few cases of Factor VII deficiency have been reported during pregnancy, a state which could potentially cause fatal haemorrhage. Here we report a case of a pregnant lady
Adil, Salman Naseem +2 more
core +1 more source
Management of anticoagulant-related intracranial hemorrhage: An evidence-based review [PDF]
, 2014 The increased use of anticoagulants for the prevention and treatment of thromboembolic diseases has led to a rising incidence of anticoagulant-related intracranial hemorrhage (AICH) in the aging western population. High mortality accompanies this form of
Keyrouz, Salah G, Ray, Bappaditya
core +3 more sources
BMC Infectious Diseases, 2007 Background This report discusses a case of unsuccessful treatment with recombinant factor VIIa (rFVIIa) in off-label use. The need for international guidelines concerning the off-label use of rFVIIa is outlined as well as the need for methods to control ...
Tsakiris Dimitrios A +3 more
doaj +1 more source
Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study [PDF]
, 2017 Objective: To evaluate the effectiveness of human recombinant activated factor VII (rhFVIIa, NovoSeven) in avoiding hysterectomy postpartum in the management of severe postpartum hemorrhage (PPH).
Alberio, Lorenzo +4 more
core
The Turkish Journal of Pediatrics, 2003 Transfusion of platelet concentrates remains the first-line therapy for Glanzmann thrombasthenia in case of bleeding or preparation for surgery. However, development of antibodies to platelet glycoprotein (Gp) IIb/IIIa complex or human leukocyte ...
Omer Devecioğlu +5 more
doaj
The use of recombinant activated factor VIIa for major bleedings in open heart surgery [PDF]
, 2008 Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/OpenINTRODUCTION: We evaluated the efficacy of activated recombinant factor VIIa (rFVIIa) administration for critical bleeding during cardiothoracic surgery in ...
Brynjar Viðarsson +4 more
core
Acta Clinica Croatica, 2015 We present the use of recombinant activated factor VIIa (rFVIIa) in a 6-month-old infant that suffered massive bleeding and subsequent coagulation disturbances during elective surgery for choroid plexus carcinoma in the lateral ventricle.
Alenka Spindler Vesel +6 more
doaj